Sep 8, 2015:
Siemens and GlaxoSmithKline, one of the world’s leading research-based pharmaceutical and healthcare companies, have entered a global strategic partnership. Siemens will become a strategic partner of GSK in manufacturing automation and thus the preferred automation supplier for GSK production and R&D sites worldwide, including Vaccines.
The partnership will provide a focus into process control, equipment control and building management systems within the manufacturing and R&D pilot plants of GlaxoSmithKline. Four main areas have been identified: Modular Manufacturing, Batch Sterile Facility Blue Print, Machine and Production Line Optimization and Manufacturing Blue Print for different Dosage forms.